Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Revvity, Inc. Common Stock
(NY:
RVTY
)
104.42
+1.60 (+1.56%)
Streaming Delayed Price
Updated: 3:17 PM EST, Feb 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Revvity, Inc. Common Stock
< Previous
1
2
3
Next >
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
March 20, 2024
From
Revvity
Via
Business Wire
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
March 18, 2024
From
Revvity
Via
Business Wire
Revvity to Present at Upcoming Investor Conferences
February 21, 2024
From
Revvity
Via
Business Wire
Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
February 12, 2024
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023
February 01, 2024
From
Revvity
Via
Business Wire
Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors
January 25, 2024
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
January 25, 2024
From
Revvity
Via
Business Wire
Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial Performance
January 09, 2024
From
Revvity
Via
Business Wire
Revvity to Present at J.P. Morgan Healthcare Conference
December 19, 2023
From
Revvity
Via
Business Wire
NYSE: RVTY Investor Notice: Investigation over Possible Securities Laws Violations by Revvity, Inc.
↗
December 11, 2023
San Diego, CA -- (SBWIRE) -- 12/11/2023 -- Revvity, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Revvity to Present at Annual Evercore ISI HealthCONx Conference
November 14, 2023
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Third Quarter of 2023
October 30, 2023
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
October 26, 2023
From
Revvity
Via
Business Wire
Revvity Debuts Inaugural ESG Report
October 26, 2023
From
Revvity
Via
Business Wire
Revvity To Hold Earnings Call on Monday, October 30, 2023
October 09, 2023
From
Revvity
Via
Business Wire
Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure
September 26, 2023
From
Revvity
Via
Business Wire
Revvity Unveils Several Next-Generation Preclinical Imaging Technologies to Help Scientists Drive Breakthrough Discoveries
September 05, 2023
From
Revvity
Via
Business Wire
Revvity to Present at Upcoming September Investor Conferences
August 23, 2023
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Second Quarter of 2023
August 01, 2023
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
July 21, 2023
From
Revvity
Via
Business Wire
Revvity Accelerates NGS Library Prep with Introduction of New Fontus Automated Liquid Handling Workstation at 2023 AACC
July 20, 2023
From
Revvity
Via
Business Wire
Revvity to Hold Earnings Call on Tuesday, August 1, 2023
July 12, 2023
From
Revvity
Via
Business Wire
Honeycomb Biotechnologies and Revvity Launch New Solutions to Expand the Frontiers of Single Cell Research
June 29, 2023
From
Revvity
Via
Business Wire
Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with New Automated IIFT System
June 01, 2023
From
Revvity
Via
Business Wire
Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development
June 12, 2023
From
Revvity
Via
Business Wire
Revvity to Present at Goldman Sachs Global Healthcare Conference
May 24, 2023
From
Revvity
Via
Business Wire
Revvity Announces New License Agreement for Next-Generation Base Editing Technology
May 18, 2023
From
Revvity
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.